M P Ball
Affiliation: University of Maryland
- A program for treating olanzapine-related weight gainM P Ball
Maryland Psychiatric Research Center at the University of Maryland School of Medicine, Baltimore 21228, USA
Psychiatr Serv 52:967-9. 2001..Only the men experienced significant weight loss. No correlation was found between weight loss and exercise or change in psychiatric symptoms...
- Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapineM Patricia Ball
Maryland Psychiatric Research Center, University of Maryland School of Medicine, Catonsville, MD 21228, USA
Clin Schizophr Relat Psychoses 5:17-25. 2011..Therefore, we examined whether atomoxetine may be of benefit for those who have gained weight on either clozapine or olanzapine...
- Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophreniaE Weiner
Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland at Baltimore, P O Box 21247, Baltimore, MD 21228, USA
Am J Psychiatry 158:635-7. 2001..The study examined the efficacy, tolerability, and safety of supportive group psychotherapy and adjunctive sustained-release bupropion for nicotine addiction in patients with schizophrenia...
- Remission in schizophrenia: the relationship to baseline symptoms and changes in symptom domains during a one-year studyD L Kelly
Maryland Psychiatric Research Center, University of Maryland, Baltimore, MD, USA
J Psychopharmacol 23:436-41. 2009..Future studies should aim to relate remission criteria to functional outcomes, cognition, and other important symptom domains...